1. Home
  2. NRSN vs XHG Comparison

NRSN vs XHG Comparison

Compare NRSN & XHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • XHG
  • Stock Information
  • Founded
  • NRSN 2017
  • XHG 2012
  • Country
  • NRSN Israel
  • XHG China
  • Employees
  • NRSN N/A
  • XHG N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • XHG
  • Sector
  • NRSN Health Care
  • XHG
  • Exchange
  • NRSN Nasdaq
  • XHG NYSE
  • Market Cap
  • NRSN 17.8M
  • XHG 15.0M
  • IPO Year
  • NRSN 2021
  • XHG 2019
  • Fundamental
  • Price
  • NRSN $1.09
  • XHG $1.14
  • Analyst Decision
  • NRSN Hold
  • XHG
  • Analyst Count
  • NRSN 1
  • XHG 0
  • Target Price
  • NRSN N/A
  • XHG N/A
  • AVG Volume (30 Days)
  • NRSN 374.5K
  • XHG 12.4M
  • Earning Date
  • NRSN 12-18-2024
  • XHG 01-24-2025
  • Dividend Yield
  • NRSN N/A
  • XHG N/A
  • EPS Growth
  • NRSN N/A
  • XHG N/A
  • EPS
  • NRSN N/A
  • XHG 210.47
  • Revenue
  • NRSN N/A
  • XHG $10,628,627.00
  • Revenue This Year
  • NRSN N/A
  • XHG N/A
  • Revenue Next Year
  • NRSN N/A
  • XHG N/A
  • P/E Ratio
  • NRSN N/A
  • XHG $0.15
  • Revenue Growth
  • NRSN N/A
  • XHG N/A
  • 52 Week Low
  • NRSN $0.51
  • XHG $0.64
  • 52 Week High
  • NRSN $2.33
  • XHG $60.00
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 47.35
  • XHG 47.46
  • Support Level
  • NRSN $1.01
  • XHG $0.90
  • Resistance Level
  • NRSN $1.13
  • XHG $3.08
  • Average True Range (ATR)
  • NRSN 0.09
  • XHG 0.39
  • MACD
  • NRSN -0.01
  • XHG 0.08
  • Stochastic Oscillator
  • NRSN 27.27
  • XHG 16.60

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About XHG XCHANGE TEC.INC SPON ADS EACH REP 600000 SHS(POST SPLIT)

XChange Tec Inc, through its subsidiaries operates in insurance agency and insurance technology business. Its insurance products include industry and/or state-owned property and casualty insurance and regional property and casualty insurance. The insurance technology business is focused on operating and developing insurance technology in the PRC, including developing SaaS platform to connect consumers and underwriting support.

Share on Social Networks: